Ricoh Biomedical

🎉 The 15th Conference on Biomolecular Screenology Has Begun! 🎉   We are excited to welcome you to our booth at the 15th Conference on Biomolecular Screenology!   Make sure to visit our booth 8 and our poster presentations in Tower Hall Funabori to explore our latest advancements in iPSC-derived differentiated cells. This is a great opportunity to learn more about how these innovations can help advance research in this field.   Don’t miss out on the opportunity to connect with our team and discover how we can advance the future of this field!   📅 Date: Nobember 22, 2024 📍 Location: Tower Hall Funabori 🔗Event Website： https://lnkd.in/eFYKRx4K   We look forward to seeing you there!   #Screenology #Biotechnology #Ricoh #iPSC #DrugDiscovery

🌟 New Case Study : Alzheimer’s Disease Research! 🌟   We are excited to introduce a new case study for evaluating glutamate uptake capacity of iPSC-derived astrocytes from Alzheimer’s disease patient with APOE4 polymorphisms.   Alzheimer’s disease (AD) is the most common form of dementia, affecting 50-60% of those with dementia worldwide. The APOE4 polymorphisms are the strongest genetic risk factor for the development of sporadic AD.   In the central nervous system, glutamate is the main excitatory neurotransmitter, that plays a crucial role in synaptic transmission. However, excess accumulation of glutamate can trigger excitotoxicity in post-synaptic neurons, contributing to neurodegeneration in AD.   To evaluate glutamate uptake capacity, we have developed astrocytes derived from iPSCs of AD patients with the APOE4 polymorphisms by measuring the concentration of glutamate in the culture supernatant. This assay system could be a valuable tool for advancing our understanding of AD pathology and supporting drug development.   For more information, please contact us. 👉https://lnkd.in/engPRADr Additionally, we will be showcasing our research at the 15th conference on biomolecular screenology on November 22.   Stay tuned for more updates on our findings!   #Ricoh　#Alzheimer’s #Alzheimer’sResearch #Alzheimer’sDisease #iPSC #APOE4 #Biotechnology #DrugDiscovery　#Neuroscience

We are excited to share the details of our four poster presentations at the 15th Conference on Biomolecular Screenology! 🌟 Dive into the latest development in our capabilities of analyzing iPSC-derived neurons.   📜 Academic Poster Presentations: １．Title: Analysis of spine formation of iPSC-derived neurons in 384-well plates Presenter: Dr. Yuina Wada Poster No:A06   ２．Title: Phenotypic analysis of neurons and astrocytes generated from iPSCs derived from Alzheimer's disease patients with APOE4 genetic polymorphisms Presenter: Dr. Rieko Tanaka Poster No:A25   ３．Title: Phenotypic analysis of a Rett syndrome model in iPSC-derived neurons Presenter: Mr. Toru Hazama Poster No:A26   📜 Commercial Poster Presentations: １．Title: The Human iPSC differentiation technology and cell function evaluation services to promote iPS-based drug discovery Presenter: Ms. Momoko　Shionoiri Poster No:B09   All poster presentations will be held at Tower Hall Funabori 2F Heian・Zuiun.   For more details on these presentations, please visit the link. https://lnkd.in/eCjQCaJp   Don't miss the chance to engage with our researchers and explore the cutting-edge developments in iPSC-derived differentiated cells. We look forward to seeing you there!   #Screenology #Biotechnology #Ricoh #iPSC #DrugDiscovery

📢 Reminder: The 12th Elixirgen Scientific Japan Webinar is Tomorrow! 📢   Don't miss out on the chance to dive into the latest strategies for improving mRNA drug development and RNA manufacturing!   Date: Tomorrow, Wednesday, November 20, 2024 ⏰ Time: 10:00 AM – 11:00 AM JST 📍 Venue: Zoom (Free to Attend)   🔍 Agenda: 🔬 Talk 1 (in English): A novel RNA polymerase variant for reduced dsRNA and simple IVT integration Speaker: Stephanie Ramos, PhD Vice President, Research & Development, Biology TriLink Biotechnologies   🔬 Talk 2 (in Japanese): Investigating Manufacturing Stability Using Clean Cap®M6 Speaker: Daisuke Takagi President Elixirgen Scientific Japan (A group company of Ricoh)   It’s not too late to register! Sign up now and learn from experts in the field. https://lnkd.in/eDxwZa8t   #ElixirgenScientific #mRNA #DrugDiscovery #CDMO #Ricoh #Biotechnology #DrugDevelopment #RNAManufacturing

🌟 Join Ricoh at the 15th Conference on Biomolecular Screenology! 🌟   We are excited to announce that we will be exhibiting at the 15th Conference on Biomolecular Screenology! We can‘t wait to showcase our latest advancements in iPSC differentiation technology at our booth and through our poster presentations.   📅 Date: Nobember 22, 2024 📍 Location: Tower Hall Funabori 🔗Event Website： https://lnkd.in/eFYKRx4K   🛠 Exhibition Information: Booth Number: 8 Location: 2F Heian・Zuiun   Come visit us to discover how we are advancing the future of this field!   #Screenology #Biotechnology #Ricoh #iPSC #DrugDiscovery

⏰ Don’t Miss Out! Last Day of Exhibition at JASP 2024! ⏰   A quick reminder that the 46th Annual Meeting of the Japanese Association for the Study of Pain(#JASP2024) is wrapping up today, and Ricoh is still showcasing our latest advancements in iPSC-derived differentiated cells at Booth 4 in the 4F WEST Hall W-4+W-5.   If you haven't had the chance yet, make sure to stop by and learn how our biotechnology has the potential to support ongoing research in pain. This is your last opportunity to see our cutting-edge innovations in action!   Thank you to everyone who has already visited our booth – we’re grateful for your interest and look forward to continuing the conversation.   We hope to see you before the exhibition closes!   📅 Date: November 17, 2024 (Today is the last day!) 📍 Location: TOC ARIAKE Convention Hall 🔗 Event Website: https://lnkd.in/e68qdnTg   #JASP2024 #Biotechnology #Ricoh #PainResearch #iPSC #DrugDiscovery

🎉 The 46th Annual Meeting of the Japanese Association for the Study of Pain Has Begun! 🎉   Today marks the first day of the 46th Annual Meeting of the Japanese Association for the Study of Pain, and Ricoh is excited to welcome you to our booth! Visit us at Booth 4 in the 4F WEST Hall W-4+W-5 to explore our latest advancements in iPSC-derived differentiated cells. This is a great opportunity to learn more about how these technologies may help advance the understanding and development of pain research.   Don’t miss out on the opportunity to connect with our team and see how Ricoh is shaping the future of biotechnology!   📅 Date: November 16-17, 2024 📍 Location: TOC ARIAKE Convention Hall 🔗 Event Website: https://lnkd.in/e68qdnTg   We look forward to seeing you there!   #JASP2024 #Biotechnology #Ricoh #iPSC #DrugDiscovery #PainResearch

🌟 New Case Study : Lewy Body Disease Research! 🌟   We are excited to introduce a new case study for evaluating α-Synuclein(α-Syn) accumulation in iPSC-derived neurons from patients with Lewy Body Disease (LBD).   A relatively high concentration of α-Syn protein, encoded by the SNCA gene, is present in synaptic vesicle membranes of neurons. An increased copy number of the SNCA gene is known to cause LBD such as Lewy body dementia, Parkinson‘s disease, and multiple system atrophy. However, current therapeutic approaches primarily focus on symptomatic treatments, and there is no curative therapy for LBD.   To evaluate α-Syn levels, we have developed excitatory neurons derived from SNCA triplication patient's iPSCs. This assay system could be used as a useful resource for advancing our understanding of LBD and potentially promoting drug development.   For more information, please contact us. 👉https://lnkd.in/engPRADr Additionally, we will be showcasing our research at the 46th Annual Meeting of the Japanese Association for the Study of Pain (JASP2024) on November 16-17.   Stay tuned for more updates on our findings!   #Ricoh #LewyBodyDisease #Parkinsons #LewyBodyDementia #iPSC #Neuroscience #Neurodegeneration #DrugDiscovery #Biotechnology #JASP2024

🌍 Join Us for the 12th Elixirgen Scientific Japan Webinar! 🌍   We are excited to announce our upcoming webinar, hosted by our group company, Elixirgen Scientific Japan, which will explore the expanding world of RNA and strategies for improving the success rate of mRNA drug development!   Date: Wednesday, November 20, 2024 ⏰ Time: 10:00 AM – 11:00 AM JST 📍 Venue: Zoom (Free to Attend)   Agenda: 🔬 Talk 1 (in English): A novel RNA polymerase variant for reduced dsRNA and simple IVT integration Speaker: Stephanie Ramos, PhD Vice President, Research & Development, Biology TriLink Biotechnologies   🔬 Talk 2 (in Japanese): Investigating Manufacturing Stability Using Clean Cap®M6 Speaker: Daisuke Takagi President Elixirgen Scientific Japan   Don’t miss out! Register now:  https://lnkd.in/eDxwZa8t   #ElixirgenScientific #mRNA #DrugDiscovery #CDMO #Ricoh #Biotechnology #DrugDevelopment #RNAManufacturing

🌟 Join Ricoh at the 46th Annual Meeting of Japanese Association for the Study of Pain! 🌟   We are excited to announce that Ricoh will be exhibiting at the 46th Annual Meeting of Japanese Association for the Study of Pain! Don’t miss the chance to explore our latest advancements in iPSC-derived differentiated cells and learn how our biotechnology may help advance research in pain.   📅 Date: Nobember 16-17, 2024 📍 Location: TOC ARIAKE Convention Hall 🔗Event Website： https://lnkd.in/e68qdnTg   🛠 Exhibition Information: Booth Number: 4 Location: 4F WEST Hall W-4+W-5   We look forward to discussing how these cutting-edge advancements in iPSC-derived differentiated cells can contribute to the next generation of treatments. Come visit us to discover how Ricoh is advancing the future of biotechnology!   #Biotechnology #Ricoh #DrugDiscovery #iPSC #JASP2024 #PainResearch